Skip to main content
Erschienen in: Diabetologia 9/2014

01.09.2014 | Article

Lipopolysaccharide binding protein, obesity status and incidence of metabolic syndrome: a prospective study among middle-aged and older Chinese

verfasst von: Xin Liu, Ling Lu, Pang Yao, Yiwei Ma, Feijie Wang, Qianlu Jin, Xingwang Ye, Huaixing Li, Frank B. Hu, Liang Sun, Xu Lin

Erschienen in: Diabetologia | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Although microbiota-derived endotoxaemia has previously been shown to induce metabolic disorders, data from population-based longitudinal studies are scarce. This study therefore investigated the associations between lipopolysaccharide binding protein (LBP) levels and 6 year incident metabolic syndrome (MetS), as well as the potentially modifying effects of obesity status in middle-aged and older Chinese men and women.

Methods

A total of 2,529 men and women aged 50–70 years from Beijing and Shanghai, China, were followed for 6 years. Those free of MetS at baseline (1,312) were included in the analyses for the risk of developing MetS. Baseline plasma LBP was measured using an ELISA kit.

Results

During the 6 year follow-up, 449 (34.2%) participants developed MetS. Baseline LBP was significantly associated with BMI, waist circumference, blood lipid profile and C-reactive protein (CRP) both at baseline and during follow-up (all p < 0.05). The RR for incident MetS comparing extreme quartiles of LBP was 1.28 (95% CI 1.04, 1.58), after multivariate adjustment including BMI and CRP. In stratified analysis, LBP was positively associated with incident MetS only in normal-weight participants (RR, comparing extreme tertiles, 1.59; 95% CI 1.18, 2.15; p trend = 0.002), but not in their overweight/obese counterparts (RR, comparing extreme tertiles, 0.99; 95% CI 0.80, 1.22; p trend = 0.880). A significant interaction was observed between LBP and obesity status (p interaction = 0.013).

Conclusions/interpretation

Our study suggested that elevated plasma LBP was associated with an increased risk of developing MetS among middle-aged and older Chinese, especially in normal-weight individuals.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Zhao L (2013) The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol 11:639–647PubMedCrossRef Zhao L (2013) The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol 11:639–647PubMedCrossRef
2.
Zurück zum Zitat Vijay-Kumar M, Aitken JD, Carvalho FA et al (2010) Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328:228–231PubMedCrossRef Vijay-Kumar M, Aitken JD, Carvalho FA et al (2010) Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328:228–231PubMedCrossRef
3.
Zurück zum Zitat Qin J, Li Y, Cai Z et al (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:55–60PubMedCrossRef Qin J, Li Y, Cai Z et al (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:55–60PubMedCrossRef
4.
Zurück zum Zitat Kemp DM (2013) Does chronic low-grade endotoxemia define susceptibility of obese humans to insulin resistance via dietary effects on gut microbiota? Adipocyte 2:188–190PubMedCentralPubMedCrossRef Kemp DM (2013) Does chronic low-grade endotoxemia define susceptibility of obese humans to insulin resistance via dietary effects on gut microbiota? Adipocyte 2:188–190PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Mehta NN, McGillicuddy FC, Anderson PD et al (2010) Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 59:172–181PubMedCentralPubMedCrossRef Mehta NN, McGillicuddy FC, Anderson PD et al (2010) Experimental endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 59:172–181PubMedCentralPubMedCrossRef
6.
Zurück zum Zitat Novitsky TJ (1998) Limitations of the Limulus amebocyte lysate test in demonstrating circulating lipopolysaccharides. Ann N Y Acad Sci 851:416–421PubMedCrossRef Novitsky TJ (1998) Limitations of the Limulus amebocyte lysate test in demonstrating circulating lipopolysaccharides. Ann N Y Acad Sci 851:416–421PubMedCrossRef
7.
Zurück zum Zitat Schumann RR (2011) Old and new findings on lipopolysaccharide-binding protein: a soluble pattern-recognition molecule. Biochem Soc Trans 39:989–993PubMedCrossRef Schumann RR (2011) Old and new findings on lipopolysaccharide-binding protein: a soluble pattern-recognition molecule. Biochem Soc Trans 39:989–993PubMedCrossRef
8.
Zurück zum Zitat Ruiz AG, Casafont F, Crespo J et al (2007) Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg 17:1374–1380PubMedCrossRef Ruiz AG, Casafont F, Crespo J et al (2007) Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes Surg 17:1374–1380PubMedCrossRef
9.
Zurück zum Zitat Sun L, Yu Z, Ye X et al (2010) A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care 33:1925–1932PubMedCentralPubMedCrossRef Sun L, Yu Z, Ye X et al (2010) A marker of endotoxemia is associated with obesity and related metabolic disorders in apparently healthy Chinese. Diabetes Care 33:1925–1932PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Teixeira TF, Souza NC, Chiarello PG et al (2012) Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clin Nutr 31:735–740PubMedCrossRef Teixeira TF, Souza NC, Chiarello PG et al (2012) Intestinal permeability parameters in obese patients are correlated with metabolic syndrome risk factors. Clin Nutr 31:735–740PubMedCrossRef
11.
Zurück zum Zitat Manco M, Putignani L, Bottazzo GF (2010) Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 31:817–844PubMedCrossRef Manco M, Putignani L, Bottazzo GF (2010) Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 31:817–844PubMedCrossRef
12.
Zurück zum Zitat Gonzalez-Quintela A, Alonso M, Campos J, Vizcaino L, Loidi L, Gude F (2013) Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity. PLoS One 8:e54600PubMedCentralPubMedCrossRef Gonzalez-Quintela A, Alonso M, Campos J, Vizcaino L, Loidi L, Gude F (2013) Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity. PLoS One 8:e54600PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Moreno-Navarrete JM, Escote X, Ortega F et al (2013) A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction. Diabetologia 56:2524–2537PubMedCrossRef Moreno-Navarrete JM, Escote X, Ortega F et al (2013) A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction. Diabetologia 56:2524–2537PubMedCrossRef
14.
Zurück zum Zitat Zong G, Zhu J, Sun L et al (2013) Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese. Am J Clin Nutr 98:319–326PubMedCrossRef Zong G, Zhu J, Sun L et al (2013) Associations of erythrocyte fatty acids in the de novo lipogenesis pathway with risk of metabolic syndrome in a cohort study of middle-aged and older Chinese. Am J Clin Nutr 98:319–326PubMedCrossRef
15.
Zurück zum Zitat Sun L, Zong G, Pan A et al (2013) Elevated plasma ferritin is associated with increased incidence of type 2 diabetes in middle-aged and elderly Chinese adults. J Nutr 143:1459–1465PubMedCrossRef Sun L, Zong G, Pan A et al (2013) Elevated plasma ferritin is associated with increased incidence of type 2 diabetes in middle-aged and elderly Chinese adults. J Nutr 143:1459–1465PubMedCrossRef
16.
Zurück zum Zitat Yu Z, Ye X, Wang J et al (2009) Associations of physical activity with inflammatory factors, adipocytokines, and metabolic syndrome in middle-aged and older chinese people. Circulation 119:2969–2977PubMedCrossRef Yu Z, Ye X, Wang J et al (2009) Associations of physical activity with inflammatory factors, adipocytokines, and metabolic syndrome in middle-aged and older chinese people. Circulation 119:2969–2977PubMedCrossRef
17.
Zurück zum Zitat Zhou BF (2002) Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults—study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 15:83–96PubMed Zhou BF (2002) Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults—study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 15:83–96PubMed
18.
Zurück zum Zitat Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112:2735–2752PubMedCrossRef Grundy SM, Cleeman JI, Daniels SR et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112:2735–2752PubMedCrossRef
19.
Zurück zum Zitat Zou G (2004) A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 159:702–706PubMedCrossRef Zou G (2004) A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 159:702–706PubMedCrossRef
20.
Zurück zum Zitat Cani PD, Amar J, Iglesias MA et al (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761–1772PubMedCrossRef Cani PD, Amar J, Iglesias MA et al (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56:1761–1772PubMedCrossRef
21.
Zurück zum Zitat Bartolome N, Aspichueta P, Martinez MJ et al (2012) Biphasic adaptative responses in VLDL metabolism and lipoprotein homeostasis during Gram-negative endotoxemia. Innate Immun 18:89–99PubMedCrossRef Bartolome N, Aspichueta P, Martinez MJ et al (2012) Biphasic adaptative responses in VLDL metabolism and lipoprotein homeostasis during Gram-negative endotoxemia. Innate Immun 18:89–99PubMedCrossRef
22.
Zurück zum Zitat Feingold KR, Staprans I, Memon RA et al (1992) Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res 33:1765–1776PubMed Feingold KR, Staprans I, Memon RA et al (1992) Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res 33:1765–1776PubMed
23.
Zurück zum Zitat Sugita H, Kaneki M, Tokunaga E et al (2002) Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab 282:E386–E394PubMed Sugita H, Kaneki M, Tokunaga E et al (2002) Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab 282:E386–E394PubMed
24.
Zurück zum Zitat Gornik I, Vujaklija A, Lukic E, Madzarac G, Gasparovic V (2010) Hyperglycemia in sepsis is a risk factor for development of type II diabetes. J Crit Care 25:263–269PubMedCrossRef Gornik I, Vujaklija A, Lukic E, Madzarac G, Gasparovic V (2010) Hyperglycemia in sepsis is a risk factor for development of type II diabetes. J Crit Care 25:263–269PubMedCrossRef
25.
Zurück zum Zitat Visschers RG, Olde Damink SW, Schreurs M, Winkens B, Soeters PB, van Gemert WG (2009) Development of hypertriglyceridemia in patients with enterocutaneous fistulas. Clin Nutr 28:313–317PubMedCrossRef Visschers RG, Olde Damink SW, Schreurs M, Winkens B, Soeters PB, van Gemert WG (2009) Development of hypertriglyceridemia in patients with enterocutaneous fistulas. Clin Nutr 28:313–317PubMedCrossRef
26.
Zurück zum Zitat Hudgins LC, Parker TS, Levine DM et al (2003) A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers. J Lipid Res 44:1489–1498PubMedCrossRef Hudgins LC, Parker TS, Levine DM et al (2003) A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers. J Lipid Res 44:1489–1498PubMedCrossRef
27.
Zurück zum Zitat Zong G, Ye X, Sun L et al (2012) Associations of erythrocyte palmitoleic acid with adipokines, inflammatory markers, and the metabolic syndrome in middle-aged and older Chinese. Am J Clin Nutr 96:970–976PubMedCentralPubMedCrossRef Zong G, Ye X, Sun L et al (2012) Associations of erythrocyte palmitoleic acid with adipokines, inflammatory markers, and the metabolic syndrome in middle-aged and older Chinese. Am J Clin Nutr 96:970–976PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911–919, quiz 920PubMedCrossRef Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911–919, quiz 920PubMedCrossRef
29.
Zurück zum Zitat Shah R, Hinkle CC, Haris L, Mehta NN, Putt ME, Reilly MP (2012) Adipose genes down-regulated during experimental endotoxemia are also suppressed in obesity. J Clin Endocrinol Metab 97:E2152–E2159PubMedCentralPubMedCrossRef Shah R, Hinkle CC, Haris L, Mehta NN, Putt ME, Reilly MP (2012) Adipose genes down-regulated during experimental endotoxemia are also suppressed in obesity. J Clin Endocrinol Metab 97:E2152–E2159PubMedCentralPubMedCrossRef
30.
Zurück zum Zitat Pini M, Castellanos KJ, Rhodes DH, Fantuzzi G (2013) Obesity and IL-6 interact in modulating the response to endotoxemia in mice. Cytokine 61:71–77PubMedCentralPubMedCrossRef Pini M, Castellanos KJ, Rhodes DH, Fantuzzi G (2013) Obesity and IL-6 interact in modulating the response to endotoxemia in mice. Cytokine 61:71–77PubMedCentralPubMedCrossRef
Metadaten
Titel
Lipopolysaccharide binding protein, obesity status and incidence of metabolic syndrome: a prospective study among middle-aged and older Chinese
verfasst von
Xin Liu
Ling Lu
Pang Yao
Yiwei Ma
Feijie Wang
Qianlu Jin
Xingwang Ye
Huaixing Li
Frank B. Hu
Liang Sun
Xu Lin
Publikationsdatum
01.09.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 9/2014
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3288-7

Weitere Artikel der Ausgabe 9/2014

Diabetologia 9/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.